Kenneth Ataga is an Oncology physician affiliated with University of Tennessee Health Science Center. OpenAlex indexes 289 publications with 10,809 citations (h-index 51); ClinicalTrials.gov lists 10 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1265 Union Ave
Memphis, TN 381043415
Telephone
901-478-2760Provider last certified this registry record 20 Apr 2026.
Clinical trials
- The Predictive Capacity of Machine Learning Models for Progressive Kidney Disease in Individuals With Sickle Cell Anemia
Sponsor: University of Tennessee
- Kidney Function in Sickle Cell Anemia
Sponsor: Kenneth Ataga MD
- Hepcidin Levels in Sickle Cell Disease (SCD)
Sponsor: Kenneth Ataga, MD
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
16 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- VERTEX PHARMACEUTICALS INCORPORATEDProgram year202519 payments$14,453openpaymentsdata.cms.gov ↗
- Octapharma USA, Inc.Program year20255 payments$13,537openpaymentsdata.cms.gov ↗
- Novo Nordisk IncProgram year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
36.4%Antimetabolite36.4%Hydroxyurea100%Part D<11 patientsMetabolism & gastrointestinal
32.5%Amino Acid32.5%Endari56%L-Glutamine44%Part D<11 patientsBlood & clotting
16.9%Selectin Blocker16.9%Adakveo100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2017–2025 per NIH RePORTER. The latest:
- Predicting Progression of Chronic Kidney Disease in Sickle Cell Anemia Using Machine Learning Models (PREMIER)
University of Tennessee Health Sci Ctr
FY2025$610,088R01HL159376 - Predicting Progression of Chronic Kidney Disease in Sickle Cell Anemia Using Machine Learning Models (PREMIER)
University of Tennessee Health Sci Ctr
FY2024$606,572R01HL159376 - Predicting Progression of Chronic Kidney Disease in Sickle Cell Anemia Using Machine Learning Models (PREMIER)
University of Tennessee Health Sci Ctr
FY2023$626,209R01HL159376
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Csaba Kovesdy, MD
University of Tennessee Health Science Center
Samuel Dagogo-Jack, MD
University of Tennessee Health Science Center
Lucas Elijovich, MD
University of Tennessee Health Science Center
Carmine Zoccali
University of Tennessee Health Science Center
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Larry Norton, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”